Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
kidney | 100% | 1454.43 | 89 / 89 | 100% | 44.41 | 901 / 901 |
ovary | 100% | 2032.02 | 180 / 180 | 100% | 85.61 | 430 / 430 |
uterus | 100% | 1836.43 | 170 / 170 | 100% | 68.97 | 459 / 459 |
esophagus | 100% | 1845.49 | 1444 / 1445 | 100% | 72.32 | 183 / 183 |
lung | 100% | 2883.07 | 578 / 578 | 100% | 65.16 | 1154 / 1155 |
intestine | 100% | 1639.29 | 966 / 966 | 100% | 68.11 | 526 / 527 |
bladder | 100% | 1874.00 | 21 / 21 | 100% | 60.94 | 503 / 504 |
thymus | 100% | 1543.70 | 652 / 653 | 100% | 68.05 | 604 / 605 |
breast | 100% | 2174.95 | 459 / 459 | 100% | 57.13 | 1114 / 1118 |
brain | 100% | 2194.85 | 2632 / 2642 | 100% | 98.06 | 705 / 705 |
skin | 100% | 1863.24 | 1808 / 1809 | 99% | 52.46 | 469 / 472 |
liver | 100% | 1235.34 | 226 / 226 | 99% | 45.65 | 403 / 406 |
prostate | 100% | 1491.52 | 244 / 245 | 100% | 34.82 | 500 / 502 |
adrenal gland | 100% | 2834.76 | 258 / 258 | 99% | 59.19 | 228 / 230 |
stomach | 99% | 1111.12 | 355 / 359 | 100% | 67.96 | 286 / 286 |
pancreas | 89% | 584.90 | 293 / 328 | 99% | 46.31 | 176 / 178 |
adipose | 100% | 2376.64 | 1204 / 1204 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 100% | 81.07 | 29 / 29 |
muscle | 100% | 4406.11 | 803 / 803 | 0% | 0 | 0 / 0 |
spleen | 100% | 3974.67 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 63.51 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 26.19 | 1 / 1 |
blood vessel | 100% | 1811.41 | 1334 / 1335 | 0% | 0 | 0 / 0 |
peripheral blood | 100% | 4133.19 | 928 / 929 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 99% | 39.46 | 79 / 80 |
heart | 97% | 1539.69 | 836 / 861 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0050871 | Biological process | positive regulation of B cell activation |
GO_0010629 | Biological process | negative regulation of gene expression |
GO_0045087 | Biological process | innate immune response |
GO_0051147 | Biological process | regulation of muscle cell differentiation |
GO_0009792 | Biological process | embryo development ending in birth or egg hatching |
GO_0000122 | Biological process | negative regulation of transcription by RNA polymerase II |
GO_0045089 | Biological process | positive regulation of innate immune response |
GO_0002250 | Biological process | adaptive immune response |
GO_0071630 | Biological process | nuclear protein quality control by the ubiquitin-proteasome system |
GO_0031144 | Biological process | proteasome localization |
GO_0006606 | Biological process | protein import into nucleus |
GO_0002821 | Biological process | positive regulation of adaptive immune response |
GO_0042742 | Biological process | defense response to bacterium |
GO_0008284 | Biological process | positive regulation of cell population proliferation |
GO_0021987 | Biological process | cerebral cortex development |
GO_0032496 | Biological process | response to lipopolysaccharide |
GO_0032755 | Biological process | positive regulation of interleukin-6 production |
GO_0045944 | Biological process | positive regulation of transcription by RNA polymerase II |
GO_0016020 | Cellular component | membrane |
GO_0005654 | Cellular component | nucleoplasm |
GO_0017053 | Cellular component | transcription repressor complex |
GO_0005737 | Cellular component | cytoplasm |
GO_0000785 | Cellular component | chromatin |
GO_0005634 | Cellular component | nucleus |
GO_0019899 | Molecular function | enzyme binding |
GO_0042802 | Molecular function | identical protein binding |
GO_0003712 | Molecular function | transcription coregulator activity |
GO_0030674 | Molecular function | protein-macromolecule adaptor activity |
GO_0005515 | Molecular function | protein binding |
Gene name | AKIRIN2 |
Protein name | Akirin-2 |
Synonyms | C6orf166 |
Description | FUNCTION: Molecular adapter that acts as a bridge between a variety of multiprotein complexes, and which is involved in embryonic development, immunity, myogenesis and brain development . Plays a key role in nuclear protein degradation by promoting import of proteasomes into the nucleus: directly binds to fully assembled 20S proteasomes at one end and to nuclear import receptor IPO9 at the other end, bridging them together and mediating the import of pre-assembled proteasome complexes through the nuclear pore . Involved in innate immunity by regulating the production of interleukin-6 (IL6) downstream of Toll-like receptor (TLR): acts by bridging the NF-kappa-B inhibitor NFKBIZ and the SWI/SNF complex, leading to promote induction of IL6 (By similarity). Also involved in adaptive immunity by promoting B-cell activation (By similarity). Involved in brain development: required for the survival and proliferation of cerebral cortical progenitor cells (By similarity). Involved in myogenesis: required for skeletal muscle formation and skeletal development, possibly by regulating expression of muscle differentiation factors (By similarity). Also plays a role in facilitating interdigital tissue regression during limb development (By similarity). . |
Accessions | ENST00000257787.6 Q53H80 |